申请人:G. D. Searle & Co.
公开号:US04628104A1
公开(公告)日:1986-12-09
This disclosure relates to a class of novel compounds of the formula: ##STR1## wherein R.sup.1 is C.sub.1 -C.sub.4 alkyl, phenyl or C.sub.1 -C.sub.4 alkylphenyl; R.sup.2 is C.sub.1 -C.sub.7 alkyl, benzyl, pyridyl, phenyl, halophenyl or dihalophenyl; and A is imidazol-1-yl, 1,2,4-triazol-1-yl or substituted imidazol-1-yl wherein the substituent is one or more groups selected from class consisting of C.sub.1 -C.sub.4 alkylthio and carboxy(C.sub.2 -C.sub.4 alkenyl); and pharmaceutically acceptable acid addition salts thereof. This invention further relates to pharmaceutical compositions containing the compounds and to the use of such compounds and compositions as anti-anaerobic agents.
这项披露涉及一类新颖化合物,其化学式为:##STR1## 其中R.sup.1为C.sub.1 -C.sub.4烷基、苯基或C.sub.1 -C.sub.4烷基苯基;R.sup.2为C.sub.1 -C.sub.7烷基、苄基、吡啶基、苯基、卤代苯基或二卤代苯基;A为咪唑-1-基、1,2,4-三唑-1-基或取代咪唑-1-基,其中取代基是来自C.sub.1 -C.sub.4烷硫基和羧基(C.sub.2 -C.sub.4烯基)等类的一个或多个基团;以及其药学上可接受的酸盐。这项发明还涉及含有这些化合物的药物组合物,以及将这些化合物和组合物用作抗厌氧剂。